Amplitude Surgical (AMPLI) H2 2025 TU earnings summary

Executive summary

• Consolidated annual revenue reached €110.8 million, up 5.7% at constant exchange rates year-over-year.

• Fourth quarter revenue grew 3.8% at constant exchange rates compared to the same quarter last year.

• France delivered 4.8% revenue growth, while international business rose 8.2% at constant exchange rates.

Financial highlights

• Full-year revenue increased 4.5% at current rates and 5.7% at constant rates year-over-year.

• Q4 revenue totaled €27.0 million, up 2.3% at current rates and 3.8% at constant rates year-over-year.

• EBITDA margin for 2024-25 is anticipated at approximately 27%, slightly above the March outlook.

Outlook and guidance

• EBITDA margin for the fiscal year ending June 30, 2025, is expected to be around 27%.

• Annual revenue was slightly below the outlook published in March 2025 due to moderate Q4 growth and unfavorable exchange rates.